Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 8
2004 2
2005 4
2006 5
2007 10
2008 5
2009 10
2010 6
2011 5
2012 5
2013 9
2014 4
2015 7
2016 4
2017 3
2018 3
2019 3
2020 4
2021 4
2022 8
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
Ezzedine K, Peeva E, Yamaguchi Y, Cox LA, Banerjee A, Han G, Hamzavi I, Ganesan AK, Picardo M, Thaçi D, Harris JE, Bae JM, Tsukamoto K, Sinclair R, Pandya AG, Sloan A, Yu D, Gandhi K, Vincent MS, King B. Ezzedine K, et al. Among authors: yamaguchi y. J Am Acad Dermatol. 2023 Feb;88(2):395-403. doi: 10.1016/j.jaad.2022.11.005. Epub 2022 Nov 9. J Am Acad Dermatol. 2023. PMID: 36370907 Free article. Clinical Trial.
Melanocytes and their diseases.
Yamaguchi Y, Hearing VJ. Yamaguchi Y, et al. Cold Spring Harb Perspect Med. 2014 May 1;4(5):a017046. doi: 10.1101/cshperspect.a017046. Cold Spring Harb Perspect Med. 2014. PMID: 24789876 Free PMC article. Review.
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo.
Guttman-Yassky E, Del Duca E, Da Rosa JC, Bar J, Ezzedine K, Ye Z, He W, Hyde C, Hassan-Zahraee M, Yamaguchi Y, Peeva E. Guttman-Yassky E, et al. Among authors: yamaguchi y. J Allergy Clin Immunol. 2024 Jan;153(1):161-172.e8. doi: 10.1016/j.jaci.2023.09.021. Epub 2023 Sep 28. J Allergy Clin Immunol. 2024. PMID: 37777018 Free article. Clinical Trial.
The regulation of skin pigmentation.
Yamaguchi Y, Brenner M, Hearing VJ. Yamaguchi Y, et al. J Biol Chem. 2007 Sep 21;282(38):27557-61. doi: 10.1074/jbc.R700026200. Epub 2007 Jul 16. J Biol Chem. 2007. PMID: 17635904 Free article. Review. No abstract available.
Molecular basis of tobacco smoke-induced premature skin aging.
Morita A, Torii K, Maeda A, Yamaguchi Y. Morita A, et al. Among authors: yamaguchi y. J Investig Dermatol Symp Proc. 2009 Aug;14(1):53-5. doi: 10.1038/jidsymp.2009.13. J Investig Dermatol Symp Proc. 2009. PMID: 19675554 Free article. Review.
Prevalence of Vitiligo Among Adults in the United States.
Gandhi K, Ezzedine K, Anastassopoulos KP, Patel R, Sikirica V, Daniel SR, Napatalung L, Yamaguchi Y, Baik R, Pandya AG. Gandhi K, et al. Among authors: yamaguchi y. JAMA Dermatol. 2022 Jan 1;158(1):43-50. doi: 10.1001/jamadermatol.2021.4724. JAMA Dermatol. 2022. PMID: 34787670 Free PMC article.
Regulation of human skin pigmentation and responses to ultraviolet radiation.
Miyamura Y, Coelho SG, Wolber R, Miller SA, Wakamatsu K, Zmudzka BZ, Ito S, Smuda C, Passeron T, Choi W, Batzer J, Yamaguchi Y, Beer JZ, Hearing VJ. Miyamura Y, et al. Among authors: yamaguchi y. Pigment Cell Res. 2007 Feb;20(1):2-13. doi: 10.1111/j.1600-0749.2006.00358.x. Pigment Cell Res. 2007. PMID: 17250543 Review.
115 results